Sodium Gluconate, Gluconic Acid, and Derivative Products From China; Determinations, 19876 [2024-05919]

Download as PDF 19876 Federal Register / Vol. 89, No. 55 / Wednesday, March 20, 2024 / Notices N.Am.I 444) and is now known as INM 444 S1. The three additional objects of cultural patrimony (projectile points) were donated by Mr. Charles Floyd in 1939 and have Object ID IA/NN 932. They are described as a set of three stone projectile points from Georgia. Each has an irregular shape and variations in color. One is grey with red veins in the stone. One is quartz-like with an opaque white and yellow surface on one side and grey granules on the opposite side. One is yellow/brown in color and appears to have a broken tip. Determinations Boston Children’s Museum has determined that: • The 16 unassociated funerary objects described in this notice are reasonably believed to have been placed intentionally with or near human remains, and are connected, either at the time of death or later as part of the death rite or ceremony of a Native American culture according to the Native American traditional knowledge of a lineal descendant, Indian Tribe, or Native Hawaiian organization. The unassociated funerary objects have been identified by a preponderance of the evidence as related to human remains, specific individuals, or families, or removed from a specific burial site or burial area of an individual or individuals with cultural affiliation to an Indian Tribe or Native Hawaiian organization. • The three objects of cultural patrimony described in this notice have ongoing historical, traditional, or cultural importance central to the Native American group, including any constituent sub-group (such as a band, clan, lineage, ceremonial society, or other subdivision), according to the Native American traditional knowledge of an Indian Tribe or Native Hawaiian organization. • There is a reasonable connection between the cultural items described in this notice and The Muscogee (Creek) Nation. khammond on DSKJM1Z7X2PROD with NOTICES Requests for Repatriation Additional, written requests for repatriation of the cultural items in this notice must be sent to the authorized representative identified in this notice under ADDRESSES. Requests for repatriation may be submitted by any lineal descendant, Indian Tribe, or Native Hawaiian organization not identified in this notice who shows, by a preponderance of the evidence, that the requestor is a lineal descendant or VerDate Sep<11>2014 16:52 Mar 19, 2024 Jkt 262001 a culturally affiliated Indian Tribe or Native Hawaiian organization. Repatriation of the cultural items in this notice to a requestor may occur on or after April 19, 2024. If competing requests for repatriation are received, Boston Children’s Museum must determine the most appropriate requestor prior to repatriation. Requests for joint repatriation of the cultural items are considered a single request and not competing requests. Boston Children’s Museum is responsible for sending a copy of this notice to the Indian Tribes and Native Hawaiian organizations identified in this notice and to any other consulting parties. Authority: Native American Graves Protection and Repatriation Act, 25 U.S.C. 3004 and the implementing regulations, 43 CFR 10.9. Dated: March 11, 2024. Melanie O’Brien, Manager, National NAGPRA Program. [FR Doc. 2024–05853 Filed 3–19–24; 8:45 am] BILLING CODE 4312–52–P in USITC Publication 5498 (March 2024), entitled Sodium Gluconate, Gluconic Acid, and Derivative Products from China: Investigation Nos. 701–TA– 590 and 731–TA–1397 (Review). By order of the Commission. Issued: March 15, 2024. Lisa Barton, Secretary to the Commission. [FR Doc. 2024–05919 Filed 3–19–24; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation Nos. 701–TA–710–711 and 731–TA–1673–1674 (Preliminary)] 2,4-Dichlorophenoxyacetic Acid (‘‘2,4D’’) From China and India; Institution of Antidumping and Countervailing Duty Investigations and Scheduling of Preliminary Phase Investigations United States International Trade Commission. ACTION: Notice. AGENCY: The Commission hereby gives notice of the institution of investigations and commencement of preliminary phase antidumping and countervailing duty investigation Nos. 701–TA–710– 711 and 731–TA–1673–1674 (Preliminary) pursuant to the Tariff Act of 1930 (‘‘the Act’’) to determine whether there is a reasonable indication that an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of 2,4-dichlorophenoxyacetic acid (‘‘2,4-D’’) from China and India, provided for in subheading 2918.99.20 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than fair value and alleged to be subsidized by the Governments of China and India. Unless the Department of Commerce (‘‘Commerce’’) extends the time for initiation, the Commission must reach a preliminary determination in antidumping and countervailing duty investigations in 45 days, or in this case by April 29, 2024. The Commission’s views must be transmitted to Commerce within five business days thereafter, or by May 6, 2024. DATES: March 14, 2024. FOR FURTHER INFORMATION CONTACT: Charles Cummings (202–708–1666), Office of Investigations, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436. Hearing-impaired persons can obtain information on this matter by contacting SUMMARY: INTERNATIONAL TRADE COMMISSION [Investigation Nos. 701–TA–590 and 731– TA–1397 (Review)] Sodium Gluconate, Gluconic Acid, and Derivative Products From China; Determinations On the basis of the record 1 developed in the subject five-year reviews, the United States International Trade Commission (‘‘Commission’’) determines, pursuant to the Tariff Act of 1930 (‘‘the Act’’), that revocation of the antidumping and countervailing duty orders on sodium gluconate, gluconic acid, and derivative products from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time. Background The Commission instituted these reviews on October 2, 2023 (88 FR 67807) and determined on January 5, 2024 that it would conduct expedited reviews (89 FR 3426, January 18, 2024). The Commission made these determinations pursuant to section 751(c) of the Act (19 U.S.C. 1675(c)). It completed and filed its determinations in these reviews on March 15, 2024. The views of the Commission are contained 1 The record is defined in § 207.2(f) of the Commission’s Rules of Practice and Procedure (19 CFR 207.2(f)). PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 E:\FR\FM\20MRN1.SGM 20MRN1

Agencies

[Federal Register Volume 89, Number 55 (Wednesday, March 20, 2024)]
[Notices]
[Page 19876]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05919]


=======================================================================
-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation Nos. 701-TA-590 and 731-TA-1397 (Review)]


Sodium Gluconate, Gluconic Acid, and Derivative Products From 
China; Determinations

    On the basis of the record \1\ developed in the subject five-year 
reviews, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the 
Act''), that revocation of the antidumping and countervailing duty 
orders on sodium gluconate, gluconic acid, and derivative products from 
China would be likely to lead to continuation or recurrence of material 
injury to an industry in the United States within a reasonably 
foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in Sec.  207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission instituted these reviews on October 2, 2023 (88 FR 
67807) and determined on January 5, 2024 that it would conduct 
expedited reviews (89 FR 3426, January 18, 2024).
    The Commission made these determinations pursuant to section 751(c) 
of the Act (19 U.S.C. 1675(c)). It completed and filed its 
determinations in these reviews on March 15, 2024. The views of the 
Commission are contained in USITC Publication 5498 (March 2024), 
entitled Sodium Gluconate, Gluconic Acid, and Derivative Products from 
China: Investigation Nos. 701-TA-590 and 731-TA-1397 (Review).

    By order of the Commission.

    Issued: March 15, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024-05919 Filed 3-19-24; 8:45 am]
BILLING CODE 7020-02-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.